Viewing Study NCT00743769


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2025-12-25 @ 8:26 PM
Study NCT ID: NCT00743769
Status: WITHDRAWN
Last Update Posted: 2017-04-17
First Post: 2008-08-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
Sponsor: RegeneRx Biopharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module